RA Capital Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.4M | Hold |
10,229,099
| – | – | 1.19% | 22 |
|
|
2025
Q1 | $29.5M | Hold |
10,229,099
| – | – | 0.49% | 32 |
|
|
2024
Q4 | $48.1M | Hold |
10,229,099
| – | – | 0.64% | 32 |
|
|
2024
Q3 | $36.5M | Sell |
10,229,099
-1,380,605
| -12% | -$4.93M | 0.42% | 46 |
|
|
2024
Q2 | $72M | Hold |
11,609,704
| – | – | 0.95% | 31 |
|
|
2024
Q1 | $110M | Hold |
11,609,704
| – | – | 1.39% | 23 |
|
|
2023
Q4 | $78.4M | Hold |
11,609,704
| – | – | 1.22% | 25 |
|
|
2023
Q3 | $51.5M | Hold |
11,609,704
| – | – | 1.01% | 29 |
|
|
2023
Q2 | $38.3M | Hold |
11,609,704
| – | – | 0.72% | 37 |
|
|
2023
Q1 | $33.1M | Buy |
11,609,704
+2,103,779
| +22% | +$6M | 0.75% | 40 |
|
|
2022
Q4 | $69.2M | Buy |
9,505,925
+2,505,925
| +36% | +$18.2M | 1.4% | 25 |
|
|
2022
Q3 | $56.6M | Buy |
+7,000,000
| New | +$56.6M | 1.21% | 31 |
|